1Shulman G I. Cellular mechanisms of insulin resistance[J].J Clin Invest,2000,106:171-176.
2Owen G I, Zelent A. Origins and evolutionary diversification of the nuclear receptor superfamily[J].Cell Mol Life Sci,2000,57:809-827.
3Dubois M, Pattou F, Kerr-Conte J, et al. Expression of peroxisome proliferator-activated receptor gamma(PPARgamma) in normal human pancreatic islet cells[J].Diabetologia,2000,43:1165-1169.
4Uchimura K, Nakamuta M, Enjoji M,et al. Activation of retinoic X receptor and peroxisome proliferator-activated receptor-gamma inhibits nitric oxide and tumor necrosis factor-alpha production in rat Kuffer cells[J].Hepatology,2001,33:91-99.
5Kersten S, Desvergne B, Wahli W. Roles of PPARs in health and disease[J].Nature,2000,405:421-424.
6Vamecq J, Latruffe N. Medical significance of peroxisome proliferator-activated receptors[J].Lancet,1999,354:141-148.
7Barroso I, Gurnell M, Crowley V E, et al. Dominant negative mutations in human PPAR gamma associated with severe insulin resistance,diabetes mellitus and hypertention[J].Nature,1999,402:880-883.
8Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverse insulin resistance associated with both lipoatrophy and obesity[J].Nat Med,2001,7:941-946.
9Chiang S H, Baumann C A, Kanzaki M, et al. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10[J].Nature,2001,410:944-948.
10Rieusset J, Chambrier C, Bouzakri K, et al. The expression of the p85 alpha subunit of phosphatidylinositol 3-kinase is induced by activation of the peroxisome proliferator-activated receptor gamma in human adipocytes[J].Diabetologia,2001,44:544-554.
10FelicityKaplan, Khulood AI - Majali, D John Bettefidge. PPARs,insulin resistance and type diabetes [ J ]. Journal of Cardiovascular Risk, 2001,8(4) :211 -216.
